Sage Therapeutics, Inc. (NASDAQ:SAGE), closed the last trading session at $154.81 with decrease of $-3.88999999999999 or -2.45 percent against the opening price of $158.7. The trading day volume of the company stands at 353061 shares while the average trading volume of Sage Therapeutics, Inc. (NASDAQ:SAGE) is 657.8 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 50.59 Million.
The price target of Sage Therapeutics, Inc. (NASDAQ:SAGE) is currently set at 200.56 by the analysts. The stock is $-18.01 Below its 1-Year High which is $188.82. SAGE hit its 1-Year low price of $79.88. The company is currently rated by analyst who are keeping a close eye on the stock as 1.6. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.
Performance Indicators of Sage Therapeutics, Inc. (NASDAQ:SAGE)
The value of the stock increased by 2.86% during the previous week performance. Looking at the 1 month performance of Sage Therapeutics, Inc. (NASDAQ:SAGE), the stock jumped 0.6%. While the 1 year performance shows a negative percentage of -13.34 and year to date performance stands at 61.61%.
Sage Therapeutics, Inc. (NASDAQ:SAGE) Analytical Review
The stock needs to grow about $45.75 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are -0.04%, 10.01% and 11.23 percent respectively. The stock trades about 8.72 percent of its Float giving its total shares Outstanding are 50.59 Million. SAGE gained about 0.81 percent in 6 months showing its Average True Range of 6.05. The company currently has a RSI and Beta of 55.02 and 2.95.
While talking about Sage Therapeutics, Inc. (NASDAQ:SAGE) valuation ratios, the stock trades with a P/S and P/B of 86.73 and 8.41 which is significantly better and attractive as compared to its peers.